Plasma adiponectin levels inversely correlate to clinical parameters in type 2 diabetes mellitus patients with macrovascular diseases

Annals of Clinical and Laboratory Science

Volumn 45, Issue 3, 2015, Pages 287-291

  Wang, Guangya ^a   Gao, Shuming ^a   Su, Na ^a   Xu, Jinxiu ^a   Fu, Dongxia ^a  

^a CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Adiponectin; Macrovascular diseases; Plasminogen activator inhibitor 1; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DONOR; ENDOCRINE FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MACROVASCULAR DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; BLOOD; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGRESSION ANALYSIS; VASCULAR DISEASES;

EID: 84934272782     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wang Y, Xu A, Knight C, et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 2002; 277: 19521-29.
2. Bacci S, Menzaghi C, Ercolino T, et al. The 9276 g/t Single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004; 27: 2015-20.
3. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-10.
4. Yang WS, Lee WJ, Funahashi T, et al. Plasma adiponectin levels in over weight and obese Asians. Obes Res 2002; 11: 1104-10.
5. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-7.
6. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25863-6.
7. Stejskal D, Ruzicka V, Adamovská S, et al. Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 167-72.
8. Fujii S, Goto D, Zaman T, et al. Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis. J Atheroscler Thromb 1998; 5: 76-81.
9. Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014; 28(1):15-23.
10. Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metabolism 2013;17(2):185-96.
11. Gao H, Fall T, van Dam RM, et al. Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity: A Mendelian Randomization Study. Diabetes 2013;62(4):1338-44.
12. Okamoto Y, Kihara S, Nishida M, et. al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767-70.